Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,027 | 832 | 99.5% |
| Education | $76.46 | 4 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $2,748 | 151 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,728 | 163 | $0 (2024) |
| ABBVIE INC. | $1,924 | 101 | $0 (2024) |
| PFIZER INC. | $917.67 | 88 | $0 (2023) |
| Janssen Biotech, Inc. | $692.97 | 48 | $0 (2023) |
| Genentech USA, Inc. | $649.47 | 36 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $648.04 | 31 | $0 (2020) |
| Lilly USA, LLC | $622.66 | 38 | $0 (2022) |
| Celgene Corporation | $426.51 | 22 | $0 (2019) |
| GlaxoSmithKline, LLC. | $280.28 | 31 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $636.96 | 43 | Novartis Pharmaceuticals Corporation ($353.39) |
| 2023 | $753.56 | 45 | Novartis Pharmaceuticals Corporation ($254.20) |
| 2022 | $820.07 | 60 | ABBVIE INC. ($344.25) |
| 2021 | $855.19 | 48 | Novartis Pharmaceuticals Corporation ($295.28) |
| 2020 | $742.90 | 40 | Amgen Inc. ($314.64) |
| 2019 | $3,648 | 219 | Amgen Inc. ($682.11) |
| 2018 | $3,755 | 216 | Amgen Inc. ($683.90) |
| 2017 | $2,893 | 165 | Amgen Inc. ($405.97) |
All Payment Transactions
836 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $5.16 | General |
| Category: Dermatology | ||||||
| 11/26/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Dermatology | ||||||
| 11/26/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $26.89 | General |
| Category: Immunology | ||||||
| 11/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Dermatology | ||||||
| 11/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Dermatology | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $6.80 | General |
| Category: Dermatology | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $8.04 | General |
| Category: Dermatology | ||||||
| 10/15/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: Inflammation | ||||||
| 10/01/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $7.97 | General |
| Category: Dermatology | ||||||
| 09/20/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Dermatology | ||||||
| 09/20/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $5.79 | General |
| Category: Dermatology | ||||||
| 09/20/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $2.28 | General |
| Category: Dermatology | ||||||
| 09/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.81 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $4.23 | General |
| Category: Dermatology | ||||||
| 09/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.32 | General |
| Category: IMMUNOLOGY | ||||||
| 08/26/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $7.02 | General |
| Category: Dermatology | ||||||
| 08/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: IMMUNOLOGY | ||||||
| 08/15/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $26.71 | General |
| Category: Dermatology | ||||||
| 08/06/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.40 | General |
| Category: IMMUNOLOGY | ||||||
| 08/01/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: IMMUNOLOGY | ||||||
| 07/24/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $8.97 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,573 | 75,152 | $2.4M | $748,763 |
| 2022 | 17 | 1,285 | 76,122 | $2.2M | $700,251 |
| 2021 | 17 | 1,294 | 68,119 | $2.1M | $712,394 |
| 2020 | 17 | 1,072 | 16,683 | $924,374 | $323,667 |
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 223 | 21,120 | $1.1M | $387,344 | 36.7% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 14 | 41,200 | $576,800 | $160,736 | 27.9% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2023 | 11 | 10,710 | $321,300 | $84,665 | 26.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 356 | 576 | $203,328 | $54,790 | 26.9% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 350 | 350 | $83,535 | $15,037 | 18.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 75 | 98 | $48,118 | $13,805 | 28.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 57 | 57 | $34,029 | $9,400 | 27.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 238 | 576 | $39,744 | $6,319 | 15.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 23 | 93 | $18,507 | $5,063 | 27.4% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 12 | 29 | $14,080 | $3,167 | 22.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 34 | 42 | $9,030 | $2,625 | 29.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 20 | 20 | $3,280 | $1,435 | 43.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 22 | $5,478 | $1,320 | 24.1% |
| 77081 | Dxa bone density measurement of forearm, finger, hand, or foot | Office | 2023 | 29 | 29 | $2,900 | $999.40 | 34.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 21 | 21 | $1,449 | $690.90 | 47.7% |
| 20600 | Aspiration and/or injection of fluid from small joint | Office | 2023 | 11 | 14 | $2,072 | $523.61 | 25.3% |
| 99422 | Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes | Office | 2023 | 13 | 16 | $1,296 | $393.76 | 30.4% |
| 99421 | Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | Office | 2023 | 16 | 16 | $656.00 | $199.52 | 30.4% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 17 | 22 | $335.00 | $133.63 | 39.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 33 | 141 | $408.90 | $118.20 | 28.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 190 | 18,422 | $921,100 | $312,275 | 33.9% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 19 | 44,400 | $621,600 | $198,791 | 32.0% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2022 | 11 | 11,342 | $282,638 | $84,616 | 29.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 315 | 541 | $190,973 | $52,399 | 27.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 81 | 119 | $58,429 | $17,303 | 29.6% |
About Dr. Susan Lemon, DO
Dr. Susan Lemon, DO is a Rheumatology healthcare provider based in Santa Barbara, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1972645513.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Susan Lemon, DO has received a total of $14,104 in payments from pharmaceutical and medical device companies, with $636.96 received in 2024. These payments were reported across 836 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($14,027).
As a Medicare-enrolled provider, Lemon has provided services to 5,224 Medicare beneficiaries, totaling 236,076 services with total Medicare billing of $2.5M. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Practice Information
- Specialty Rheumatology
- Location Santa Barbara, CA
- Active Since 02/12/2007
- Last Updated 01/31/2019
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1972645513
Products in Payments
- COSENTYX (Biological) $2,022
- Enbrel (Biological) $1,780
- Humira (Biological) $714.55
- XELJANZ (Drug) $621.28
- COSENTYX (Drug) $607.59
- RINVOQ (Biological) $568.75
- TALTZ (Drug) $532.76
- Rituxan (Biological) $529.62
- SIMPONI ARIA (Biological) $517.53
- ORENCIA (Biological) $404.53
- Prolia (Biological) $355.74
- BENLYSTA (Biological) $280.28
- EVENITY (Biological) $274.87
- ACTHAR (Biological) $261.63
- SKYRIZI (Biological) $229.58
- Rinvoq (Biological) $228.89
- KRYSTEXXA (Drug) $209.98
- MONOVISC (Device) $205.34
- KRYSTEXXA (Biological) $179.80
- KEVZARA (Drug) $179.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Santa Barbara
Stuart Segal, M.d, M.D
Rheumatology — Payments: $162,377
Hans Richard Barthel, M.d, M.D
Rheumatology — Payments: $32,207
Christian Powell
Rheumatology — Payments: $21,653
Sara Taroumian, M.d, M.D
Rheumatology — Payments: $17,319
Dr. Timothy Spiegel, M.d, M.D
Rheumatology — Payments: $12,362
Guy Clark, Md, MD
Rheumatology — Payments: $3,579